BioMarin to Participate in the Virtual BofA Securities 2021 Napa Biopharma Conference

BioMarin to Participate in the Virtual BofA Securities 2021 Napa Biopharma Conference

PR Newswire

SAN RAFAEL, Calif., June 15, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in the BofA Securities 2021 Napa Biopharma Conference on June 16, 2021 at 3:30pm ET. An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:




Investors                                                          

Media

Traci McCarty                                                   

Debra Charlesworth

BioMarin Pharmaceutical Inc.                            

BioMarin Pharmaceutical Inc.

(415) 455-7558                                                   

(415) 455-7451

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-the-virtual-bofa-securities-2021-napa-biopharma-conference-301312288.html

SOURCE BioMarin Pharmaceutical Inc.

Copyright CNW Group 2021